West Palm Beach, FL– (September 29, 2005) – Hologic, Inc. (NASDAQ: HOLX), a leading provider of diagnostic imaging and state-of-the-art digital imaging systems directed towards women’s health, today announced it has completed the acquisition of Fischer Imaging Corporation’s intellectual property relating to its mammography business and products, including the rights to their SenoScan digital mammography and MammoTest stereotactic breast biopsy systems. Fischer Imaging Corporation, a ComVest Investment Partners Portfolio Company, is located in Denver, Colorado and designs, manufactures and markets medical imaging systems for the screening and diagnosis of breast cancer. The cash purchase price for Fischer Imaging’s assets was approximately $32 million.

“As a company, we have been focused on expanding our market share in women’s health,” said Jack Cumming, Chairman and Chief Executive Officer. “We have every expectation that this acquisition will strengthen our leadership position in the growing current and future mammography market.”

For additional information on the transaction, please view Hologic’s press releases at: www.hologic.com.

About ComVest Investment Partners
ComVest Investment Partners is a private equity firm focused on restructuring and investing in growth businesses. The firm has a diversified industry focus that includes Information Technology, Healthcare, Aerospace and Defense, Natural Resources, Consumer Packaged Goods, and Telecommunications. Since its founding in 1988, ComVest has raised and invested more than $1.4 billion of capital. ComVest currently manages three investment portfolios totaling over $850 million in assets and has offices in New York City and West Palm Beach, Florida.

For additional information, please visit www.comvest.com or contact: